Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Waldenstrom Macroglobulinemia × Immunoenzyme Techniques × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 5 Lung Neoplasms 4 Breast Neoplasms, Male 3 Breast Neoplasms 3 Sarcoma 2 Prostatic Neoplasms 2 Neoplasm Metastasis 2 Kidney Neoplasms 2 Central Nervous System Neoplasms 2 Carcinoma, Renal Cell 2 Carcinoma, Hepatocellular 2 Brain Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 1 Ovarian Neoplasms 1 Osteosarcoma 1 Oligodendroglioma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neoplasms, Plasma Cell 1 Neoplasms 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Mesothelioma, Malignant 1 Melanoma 1 Liver Neoplasms 1 Liposarcoma 1 Leukemia 1 Hepatitis C 1 Head and Neck Neoplasms 1 Gliosarcoma 1 Glioma, Subependymal 1

Interventions

Rituximab 44 fludarabine phosphate 24 Cyclophosphamide 22 Whole-Body Irradiation 21 Peripheral Blood Stem Cell Transplantation 19 Mycophenolic Acid 18 Cyclosporine 14 Tacrolimus 13 Dexamethasone 13 ibrutinib 11 Bortezomib 11 Calcium Dobesilate 10 Busulfan 10 Antilymphocyte Serum 9 Sirolimus 8 Etoposide 8 Methotrexate 7 Lenalidomide 7 Cyclosporins 7 Melphalan 6 Everolimus 6 idelalisib 5 Filgrastim 5 thymoglobulin 4 carfilzomib 4 Indium 4 In Situ Hybridization, Fluorescence 4 Granulocyte Colony-Stimulating Factor 4 Flow Cytometry 4 pembrolizumab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡